药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Clotiazepam
Sotatercept
Estradiol valerate may increase the thrombogenic activities of Sotatercept.
Clotiazepam
Tarextumab
Estradiol valerate may increase the thrombogenic activities of Tarextumab.
Clotiazepam
Fulranumab
Estradiol valerate may increase the thrombogenic activities of Fulranumab.
Clotiazepam
Patritumab
Estradiol valerate may increase the thrombogenic activities of Patritumab.
Clotiazepam
Urelumab
Estradiol valerate may increase the thrombogenic activities of Urelumab.
Clotiazepam
Visilizumab
Estradiol valerate may increase the thrombogenic activities of Visilizumab.
Clotiazepam
Gantenerumab
Estradiol valerate may increase the thrombogenic activities of Gantenerumab.
Clotiazepam
Benralizumab
Estradiol valerate may increase the thrombogenic activities of Benralizumab.
Clotiazepam
Ocrelizumab
Estradiol valerate may increase the thrombogenic activities of Ocrelizumab.
Clotiazepam
Anifrolumab
Estradiol valerate may increase the thrombogenic activities of Anifrolumab.
Clotiazepam
Rilotumumab
Estradiol valerate may increase the thrombogenic activities of Rilotumumab.
Clotiazepam
Crenezumab
Estradiol valerate may increase the thrombogenic activities of Crenezumab.
Clotiazepam
Avelumab
Estradiol valerate may increase the thrombogenic activities of Avelumab.
Clotiazepam
Varlilumab
Estradiol valerate may increase the thrombogenic activities of Varlilumab.
Clotiazepam
Lebrikizumab
Estradiol valerate may increase the thrombogenic activities of Lebrikizumab.
Clotiazepam
Vadastuximab Talirine
Estradiol valerate may increase the thrombogenic activities of Vadastuximab Talirine.
Clotiazepam
Romosozumab
Estradiol valerate may increase the thrombogenic activities of Romosozumab.
Clotiazepam
Landogrozumab
Estradiol valerate may increase the thrombogenic activities of Landogrozumab.
Clotiazepam
Seribantumab
Estradiol valerate may increase the thrombogenic activities of Seribantumab.
Clotiazepam
Ligelizumab
Estradiol valerate may increase the thrombogenic activities of Ligelizumab.